Literature DB >> 1584326

Exacerbation of latent heart failure by mild hypocalcemia after parathyroidectomy in a long-term hemodialysis patient.

T Shinoda1, T Aizawa, T Shirota, M Katakura, T Yamada, H Arakura, Y T Chang, S Kobayashi, T Mizukami.   

Abstract

A 60-year-old uremic patient treated with hemodialysis for 13 years developed acute hypotension during hemodialysis and overt heart failure subsequently in a period of relatively mild hypocalcemia after parathyroidectomy. Blood pressure during hemodialysis was maintained by continuous calcium infusion alone. Cardiomegaly was improved by normalization of serum calcium. The cardiac complication is considered to be exacerbation of the underlying myocardial dysfunction by the acute decline of serum calcium which might be a feature of the 'hungry bone' syndrome. Latent myocardial dysfunction might be exacerbated by only mild hypocalcemia after parathyroidectomy in long-term hemodialysis patients.

Entities:  

Mesh:

Year:  1992        PMID: 1584326     DOI: 10.1159/000186813

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Pseudohypoparathyroidism and Cardiomyopathy: A Case Report with a New Perspective on the Cardiovascular-Endocrine Axis with Respect to Calcium Homeostasis.

Authors:  Anum Fasih
Journal:  Eur J Case Rep Intern Med       Date:  2019-02-15

2.  Fatal Hypocalcaemia Due to Hungry Bone Syndrome with Secondary Refractory HyperParathyroidism After Parathyroidectomy: A Case Report.

Authors:  Corina Pop Radu; Valentin Daniealopol; Ario Santini; Ruxandra Darie; Daniela Tatiana Sala
Journal:  J Crit Care Med (Targu Mures)       Date:  2019-11-27

Review 3.  Hypocalcaemic cardiomyopathy: a description of two cases and a literature review.

Authors:  Martin Válek; Lenka Roblová; Ivan Raška; Dita Schaffelhoferová; Tomáš Paleček
Journal:  ESC Heart Fail       Date:  2020-04-03

4.  Incidence of and risk factors for post-parathyroidectomy hungry bone syndrome in patients with secondary hyperparathyroidism.

Authors:  Kittrawee Kritmetapak; Sawinee Kongpetch; Wijittra Chotmongkol; Yutapong Raruenrom; Sakkarn Sangkhamanon; Chatlert Pongchaiyakul
Journal:  Ren Fail       Date:  2020-11       Impact factor: 2.606

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.